As in a recent breast cancer study [18], the tumour suppressor gene BRCA1 and particularly the single-nucleotide variants (SNVs) in this gene’s exons are focused on understanding the functionally critical domains of BRCA1 and the related clinically actionable genes [19]. This evidence concerns the gene BRCA1 and breast carcinoma.